Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.12 USD | +5.08% | +5.40% | +29.82% |
04-26 | Corebridge Financial, Inc. Announces Board Changes | CI |
04-15 | Morgan Stanley Adjusts Corebridge Financial's Price Target to $28 From $26, Keeps Equalweight Rating | MT |
Chart calendar Corebridge Financial, Inc.
Upcoming events on Corebridge Financial, Inc.
Past events on Corebridge Financial, Inc.
15/02/2024 13:30 | Q4 2023 Earnings Call |
15/02/2024 11:00 | Q4 2023 Earnings Release |
03/11/2023 12:30 | Q3 2023 Earnings Call |
03/11/2023 10:00 | Q3 2023 Earnings Release |
04/08/2023 13:30 | Q2 2023 Earnings Call |
04/08/2023 11:00 | Q2 2023 Earnings Release |
20/06/2023 13:30 | Annual General Meeting |
09/05/2023 13:30 | Q1 2023 Earnings Call |
09/05/2023 11:00 | Q1 2023 Earnings Release |
17/02/2023 13:30 | FY 2022 Earnings Call |
17/02/2023 11:00 | FY 2022 Earnings Release |
09/11/2022 13:30 | Q3 2022 Earnings Call |
09/11/2022 11:00 | Q3 2022 Earnings Release |
Past dividends on Corebridge Financial, Inc.
13/03/2024 | Quarterly 0.23 USD |
13/12/2023 | Quarterly 0.23 USD |
09/11/2023 | 1.16 USD |
13/09/2023 | Quarterly 0.23 USD |
14/06/2023 | Quarterly 0.23 USD |
14/06/2023 | 0.62 USD |
15/03/2023 | Quarterly 0.23 USD |
14/12/2022 | Quarterly 0.23 USD |
05/10/2022 | Quarterly 0.23 USD |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 18 056 17 976 0.45% | 21 212 20 752 2.22% | 22 953 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 2 544 2 494 2.01% | 3 125 3 695 -15.43% | 4 235 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Net income Million USD | Released Forecast Spread | 8 149 9 036 -9.82% | 1 104 2 751 -59.87% | 2 858 |
EPS USD | Released Forecast Spread | 12,6 13,9 -9.42% | 1,71 4,41 -61.25% | 4,71 |
Announcement Date | 17/02/23 | 15/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4 441 4 165 6.63% | 5 369 5 292 1.46% | 5 363 4 273 25.5% | 5 845 4 481 30.45% | 4 081 5 110 -20.14% | 5 923 5 493 7.82% | 5 440 | 5 816 | 5 581 | 6 086 | 5 954 |
EBIT Million USD | Released Forecast Spread | 549 574 -4.36% | 706 721 -2.08% | 945 954 -0.94% | 909 949 -4.21% | 798 912 -12.5% | 921 | 1 077 | 1 130 | 1 163 | ||
Net income Million USD | Released Forecast Spread | 2 351 219 973.52% | -566 317 -278.83% | -459 397 -215.76% | 771 508 51.63% | 2 101 604 248.07% | -1 309 543 -341.11% | 637 | 723 | 747 | 754 | 764 |
EPS USD | Released Forecast Spread | 3,63 1,16 212.48% | -0,87 0,43 -302.39% | -0,70 0,61 -215.38% | 1,18 0,80 47.2% | 3,28 0,94 250.52% | -2,07 0,86 -340.37% | 1,01 | 1,17 | 1,25 | 1,30 | 1,34 |
Announcement Date | 09/11/22 | 17/02/23 | 09/05/23 | 04/08/23 | 03/11/23 | 15/02/24 | - | - | - | - | - |
Past sector events for Corebridge Financial, Inc.
02/05/2024 16:45 | AXA: Q1 2024 Sales and Revenue Release - Activities Report |
02/05/2024 12:00 | LINCOLN NATIONAL CORPORATION: Q1 2024 Earnings Release |
01/05/2024 | HANWHA CORPORATION: Q1 2024 Earnings Release |
30/04/2024 | METLIFE, INC.: Q1 2024 Earnings Release |
30/04/2024 | AFLAC INCORPORATED: Q1 2024 Earnings Release |
30/04/2024 | GREAT-WEST LIFECO INC.: Q1 2024 Earnings Release |
30/04/2024 21:15 | UNUM GROUP: Q1 2024 Earnings Release |
30/04/2024 21:15 | PRUDENTIAL FINANCIAL, INC.: Q1 2024 Earnings Release |
29/04/2024 | HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
29/04/2024 | HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRBG Stock
- Calendar Corebridge Financial, Inc.